While giving birth can be an overwhelming experience for many, science has figured out a connection between gestational diabetes mellitus (GDM) disease that restricts insulin circulation to the baby and pregnancy weight. The study published in Nature Communications Medicine talks about the difficulty during pregnancy.
Traditionally, standard treatments for GDM have not consistently produced positive results. The study suggests a shift towards exploring non-glycemic markers like insulin profiles and triglyceride levels to better assess the risks associated with GDM.
Ellen C. Francis, an assistant professor at Rutgers School of Public Health, stressed that only recently has there been a focus on markers such as clinical, biochemical, or sociocultural factors that could help identify those at the greatest risk of poor outcomes.
The lead author of the study mentioned that future diagnosis of GDM might involve combining anthropometric or biochemical information with existing methods. However, the study also highlighted the need for more research to establish direct links between insulin resistance, higher triglycerides, and negative pregnancy outcomes.
In conclusion, the findings suggest potential improvements in diagnosing GDM by incorporating additional information alongside current methods. The researchers recommend further studies, including investigations into precision biomarkers, diverse population assessments, and exploration of genetic and multi-omics data to understand the variations in GDM and its outcomes.
